These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19341543)

  • 41. The physician's duty and role in communicating with family members regarding results of patients' genetic testing.
    Hall SC
    J Ky Med Assoc; 2005 Apr; 103(4):159-61. PubMed ID: 15853183
    [No Abstract]   [Full Text] [Related]  

  • 42. Learning about genetic risk. Weighing the risk with the right to know.
    Dorinzi D
    AWHONN Lifelines; 1999; 3(5):49-52. PubMed ID: 10827584
    [No Abstract]   [Full Text] [Related]  

  • 43. Should doctors have a legal duty to warn relatives of their genetic risks?
    Middleton A; Milne R; Robarts L; Roberts J; Patch C
    Lancet; 2019 Dec; 394(10215):2133-2135. PubMed ID: 31784025
    [No Abstract]   [Full Text] [Related]  

  • 44. Counseling in congenital heart defects.
    Callan NA; Blakemore KJ; Kan JS
    Obstet Gynecol Surv; 1991 Oct; 46(10):651-5. PubMed ID: 1945195
    [No Abstract]   [Full Text] [Related]  

  • 45. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing for cancer susceptibility genes in children.
    Laxova R
    Adv Pediatr; 1999; 46():1-40. PubMed ID: 10645460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
    Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
    Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic Service Delivery Models: Exploring Approaches to Care for Families With Hereditary Cancer Risk.
    Pierle JM; Mahon SM
    Clin J Oncol Nurs; 2019 Feb; 23(1):60-67. PubMed ID: 30681998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession.
    Wolff ND; Wolff JA
    J Genet Couns; 2018 Jun; 27(3):521-527. PubMed ID: 29524069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The general practitioner and the "new genetics".
    Mann L
    Med J Aust; 2003 Jul; 179(2):109-11. PubMed ID: 12864725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests.
    Kilbride MK; Domchek SM; Bradbury AR
    JAMA Oncol; 2018 Oct; 4(10):1327-1328. PubMed ID: 30027223
    [No Abstract]   [Full Text] [Related]  

  • 52. Hereditary breast cancer. Psychosocial issues and family physicians' role.
    Carroll JC; Heisey RE; Warner E; Goel V; McCready DR
    Can Fam Physician; 1999 Jan; 45():126-32. PubMed ID: 10889865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opportunities, Risks, and Limitations of Genetic Testing: Looking to the Future From Patients' Point of View.
    Bertolotti M
    Mayo Clin Proc; 2015 Oct; 90(10):1311-3. PubMed ID: 26434956
    [No Abstract]   [Full Text] [Related]  

  • 55. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
    Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dealing with the uncertainty of developing a cancer.
    Murphy AE
    Eur J Cancer Care (Engl); 1999 Dec; 8(4):233-7. PubMed ID: 10889621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Genetic counseling in congenital long QT syndrome].
    Hamang A; Solberg B; Bjorvatn C; Greve G; Øyen N
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1226-9. PubMed ID: 19521446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physician's duty to warn third parties about the risk of genetic diseases.
    McAbee GN; Sherman J; Davidoff-Feldman B
    Pediatrics; 1998 Jul; 102(1 Pt 1):140-2. PubMed ID: 9714638
    [No Abstract]   [Full Text] [Related]  

  • 59. The Life Course Perspective: a Guide for Genetic Counselors.
    Hamilton RJ; Innella NA; Bounds DT
    J Genet Couns; 2016 Feb; 25(1):44-8. PubMed ID: 26306684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What should we know about personal genetic testing?
    Gelo F
    J Pastoral Care Counsel; 2013; 67(3-4):10. PubMed ID: 24720249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.